These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1161 related articles for article (PubMed ID: 22460880)

  • 21. Why clinical translation cannot succeed without failure.
    London AJ; Kimmelman J
    Elife; 2015 Nov; 4():e12844. PubMed ID: 26599839
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reproducibility, relevance and reliability as barriers to efficient and credible biomedical technology translation.
    Dirnagl U; Duda GN; Grainger DW; Reinke P; Roubenoff R
    Adv Drug Deliv Rev; 2022 Mar; 182():114118. PubMed ID: 35066104
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The lessons of failure: clinical flops are helping researchers define the keys to successful cancer drug trials.
    Nelson B
    Cancer Cytopathol; 2012 Dec; 120(6):359-60. PubMed ID: 23242934
    [No Abstract]   [Full Text] [Related]  

  • 24. Cancer research. As questions grow, Duke halts trials, launches investigation.
    Couzin-Frankel J
    Science; 2010 Aug; 329(5992):614-5. PubMed ID: 20688986
    [No Abstract]   [Full Text] [Related]  

  • 25. Designed Learning: Missing Data in Clinical Research.
    Stack CB; Butterworth T; Goldin R
    Ann Intern Med; 2018 May; 168(10):744. PubMed ID: 29632949
    [No Abstract]   [Full Text] [Related]  

  • 26. Reverse translation of failed treatments can help improving the validity of preclinical animal models.
    't Hart BA
    Eur J Pharmacol; 2015 Jul; 759():14-8. PubMed ID: 25823810
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The case for introducing pre-registered confirmatory pharmacological pre-clinical studies.
    Kiwanuka O; Bellander BM; Hånell A
    J Cereb Blood Flow Metab; 2018 May; 38(5):749-754. PubMed ID: 29480040
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of new epilepsy treatments: issues in preclinical methodology.
    Galanopoulou AS; Buckmaster PS; Staley KJ; Moshé SL; Perucca E; Engel J; Löscher W; Noebels JL; Pitkänen A; Stables J; White HS; O'Brien TJ; Simonato M;
    Epilepsia; 2012 Mar; 53(3):571-82. PubMed ID: 22292566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Personalized-medicine trials on the rise.
    Benowitz S
    J Natl Cancer Inst; 2012 Oct; 104(19):1425-6. PubMed ID: 23008496
    [No Abstract]   [Full Text] [Related]  

  • 30. Above and Beyond Cancer Therapy: Translating Biomaterials into the Clinic.
    Conde J
    Trends Cancer; 2020 Sep; 6(9):730-732. PubMed ID: 32430152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-risk molecules or insufficient scientific data?
    Mignot A
    Clin Pharmacol Ther; 2008 Feb; 83(2):365-7. PubMed ID: 18091760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Consider drug efficacy before first-in-human trials.
    Kimmelman J; Federico C
    Nature; 2017 Jan; 542(7639):25-27. PubMed ID: 28150789
    [No Abstract]   [Full Text] [Related]  

  • 33. A plea for "omics" research in complex diseases such as multiple sclerosis--a change of mind is needed.
    Martin R; Leppert D
    J Neurol Sci; 2004 Jul; 222(1-2):3-5. PubMed ID: 15240188
    [No Abstract]   [Full Text] [Related]  

  • 34. Ensuring Scientific Publishing Credibility in Translational Biomedical Optics.
    Pogue BW
    J Biomed Opt; 2019 Jan; 24(1):1-3. PubMed ID: 30632356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. European Academy of Cancer Sciences-Designation of Comprehensive Cancer Centres of Excellence.
    Ringborg U; Celis J; Eggermont A; Berns A
    Eur J Cancer; 2018 Apr; 93():138-139. PubMed ID: 29454744
    [No Abstract]   [Full Text] [Related]  

  • 36. Prepping omics for the clinic.
    Tuma RS
    J Natl Cancer Inst; 2012 May; 104(10):727-8. PubMed ID: 22544945
    [No Abstract]   [Full Text] [Related]  

  • 37. Contaminated and misidentified cell lines commonly use in cancer research.
    Cheung ST; Chan SL; Lo KW
    Mol Carcinog; 2020 Jun; 59(6):573-574. PubMed ID: 32196757
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A meta-analysis of threats to valid clinical inference in preclinical research of sunitinib.
    Henderson VC; Demko N; Hakala A; MacKinnon N; Federico CA; Fergusson D; Kimmelman J
    Elife; 2015 Oct; 4():e08351. PubMed ID: 26460544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of fraudulent and irreproducible data to the translational research crisis - solutions and implementation.
    Schulz JB; Cookson MR; Hausmann L
    J Neurochem; 2016 Oct; 139 Suppl 2():253-270. PubMed ID: 27797406
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancer: Reshaping the cancer clinic.
    Schmidt C
    Nature; 2015 Nov; 527(7576):S10-1. PubMed ID: 26536216
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 59.